The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Yahia Elgharib, Karim Medhat, Fayrouz Fouad, Faten Elgharib, Ekram Saleh. Female and male hormonal-dependent malignancies: the role of long non-coding RNAs, Medical Oncology. 2025; 42: 444. https://doi.org/10.1007/s12032-025-03001-y |
|
2 |
2026 |
M. O. Silkina, T. A. Kulagin, K. V. Klycheva, A. D. Shatsillo, M. D. Mastykina, A. V. Razumovskaya, K. M. Nyushko, S. V. Nikulin. Expression of Antioxidant Defense Genes Determines Synergistic Ferroptosis Induction by the Combination of Erastin and Omega-3 Docosahexaenoic Acid in Prostate Cancer Cells, Doklady Biochemistry and Biophysics. 2026; 526: 11. https://doi.org/10.1134/S1607672925601660 |
|
3 |
2026 |
Ranyelison Silva Machado, Kaio S. Gomes, Augusto B. Farias, Natália Meneses Araújo, Giovanna Barbosa Chanes, Laura Maria Pinto Dias, Bianca Zaia Franco Ferreira, Carla Cristina Lopes, Ileana G. S. Rubio, Fernando Moreira Simabuco, Daniela G. G. Rando, Hugo Pequeno Monteiro, Adolfo Garcia Erustes, Soraya Soubhi Smaili, David Ryffel, David Sarlah, Giselle Cerchiaro, João Henrique G. Lago, Rodrigo Esaki Tamura. Overcoming Docetaxel Resistance in Prostate Cancer by Targeting Cell Cycle Progression with Narciclasine-Based Compounds, ACS Omega. 2026; https://doi.org/10.1021/acsomega.6c05272 |
|
4 |
2025 |
Abdulghani A Naeem, Saud A Abdulsamad. Molecular Mechanisms of Castration-Resistant Prostate Cancer Progression, Cureus. 2025; https://doi.org/10.7759/cureus.83813 |
|
5 |
2026 |
Ayesha Jabeen, Tabish Javeed, Nusrat Jan, Shazia Sofi, Gowhar Masoodi, Showkat Ahmad Ahanger, Manzoor Ahmad Mir. Targeting the JAK/STAT signalling axis in cancer: chemopreventive potential of natural compounds with emerging focus on retinoids, Clinical and Translational Oncology. 2026; https://doi.org/10.1007/s12094-026-04540-0 |
|
6 |
2025 |
Boga Vijay Kumar, Riya Sachan, Prajakta Garad, Nidhi Srivastava, Shubhini A. Saraf, Niranjan Meher. Dual Targeting of Prostate-Specific Membrane Antigen and Fibroblast Activation Protein: Bridging Prostate Cancer Theranostics with Precision, ACS Applied Bio Materials. 2025; 8: 962. https://doi.org/10.1021/acsabm.4c01914 |
|
7 |
2025 |
MohammadMostafa Askarnia Faal, Tandiseh Tasbandi, Mahdieh Aliyari, Maryam Shojaei, Moeen Eskandari, Amirhossein Sahebkar, Hossein Hosseini, Mohammad Jalili-Nik. Synergistic effects of Calebin A and docetaxel on apoptosis and migration in prostate cancer cells, DARU Journal of Pharmaceutical Sciences. 2025; 34: 3. https://doi.org/10.1007/s40199-025-00579-6 |
|
8 |
2025 |
Yuanzhi Fu, Junhao Chen, Xingcheng Zhu, Mingxia Ding, Haifeng Wang, Shi Fu. Roles and therapeutic potential of the SLC family in prostate cancer—literature review, BMC Urology. 2025; 25: 32. https://doi.org/10.1186/s12894-025-01714-w |
|
9 |
2025 |
Brahmi Shenoy, Miloni Mandani, Meena Chintamaneni, Sonal M. Manohar. Combination of the First-in-Class Imipridone ONC201 and Standard Anticancer Therapies as a Rational Approach for Therapeutic Benefit, Current Issues in Molecular Biology. 2025; 47: 775. https://doi.org/10.3390/cimb47090775 |
|
10 |
2026 |
Hikmet Öztop, Erdem Çubukçu. Comparison of Androgen Receptor Pathway Inhibitors and Cabazitaxel Following Docetaxel in Metastatic Castration-Resistant Prostate Cancer: A Real-World Retrospective Cohort Study, DAHUDER Medical Journal. 2026; 9. https://doi.org/10.56016/dahudermj.1797021 |
|
11 |
2026 |
Gustavo A. Sosa, Betsy Crosswhite, Austin N. Kirschner. Cellular signaling and radioresistance in prostate cancer, Cellular Signalling. 2026; 141: 112367112367. https://doi.org/10.1016/j.cellsig.2026.112367 |
|
12 |
2026 |
Zhongze Li, Jinrun Wang, Lizhe Xu, Jinzhuo Ning, Fan Cheng. CRLF1 Drives Prostate Cancer Progression via COMP-Mediated Activation of the FAK/PI3K/AKT Signaling Pathway, Cancers. 2026; 18: 1395. https://doi.org/10.3390/cancers18091395 |
|
13 |
2026 |
Ruijie Mao, Xu Chen, Xing Fu, Dingyuan Yang, Wenqiang Chen, Jun Li. Histone lactylation modification promotes docetaxel resistance and tumor progression through CNN1-Mediated autophagy and cell cycle arrest in Castration-resistant prostate cancer, Cell Death Discovery. 2026; 12: 259. https://doi.org/10.1038/s41420-026-03141-8 |
|
14 |
2026 |
Sashana Dixon, Nicola Ewen Hall, Karelys Diaz-Davila, Helen A. Crentsil, Ana M. Castejon, Richard N. L. Lamptey. Emerging Therapeutic Targets in Castration-Resistant Prostate Cancer, Onco. 2026; 6: 19. https://doi.org/10.3390/onco6020019 |
|
15 |
2025 |
Sergey A. Dyshlovoy, Jessica Hauschild, Malte Kriegs, Konstantin Hoffer, Olga Y. Burenina, Nadja Strewinsky, Timofey V. Malyarenko, Alla A. Kicha, Natalia V. Ivanchina, Valentin A. Stonik, Markus Graefen, Carsten Bokemeyer, Gunhild von Amsberg. Anticancer activity of triterpene glycosides from the sea star Solaster pacificus, Scientific Reports. 2025; 15: 28410. https://doi.org/10.1038/s41598-025-12914-7 |